Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The LUTADOSE trial: tumour dosimetry after the first admi... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu]Lu-DOTATATE
0
Authors
Marco Maccauro
14 more
Marco Maccauro
•
Mariarosaria Cuomo
12 more
•
Carlo Chiesa
Published
September 5, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
European Journal of Nuclear Medicine and Molecular Imaging
Topics
Medicine
Cancer Oncology
Epidemiology
Internal Medicine
Neurology
Show all topics
DOI
10.1007/s00259-024-06863-y
